Al-Essa, Mazen <br/><br/>
Selective receptor-mediated impairment of growth factor activity in neonatal- and X-linked adrenoleukodystrophy patients.  [electronic resource] 

 -  Journal of pediatric endocrinology & metabolism : JPEM  Jul 2019 
 - 733-738 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2191-0251 
<br/><br/><label>Standard No.: </label>10.1515/jpem-2018-0540  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenoleukodystrophy--drug therapy<br/>Biomarkers--metabolism<br/>Case-Control Studies<br/>Cells, Cultured<br/>Child, Preschool<br/>Female<br/>Fibroblast Growth Factor 2--pharmacology<br/>Fibroblasts--drug effects<br/>Follow-Up Studies<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Infant<br/>Insulin-Like Growth Factor I--pharmacology<br/>Male<br/>Peroxisomal Disorders--drug therapy<br/>Platelet-Derived Growth Factor--pharmacology<br/>Receptor, Fibroblast Growth Factor, Type 1--metabolism<br/>Receptor, IGF Type 1--metabolism<br/>Receptors, Platelet-Derived Growth Factor--metabolism<br/>Skin--drug effects